Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Microchip Technology's Path To Recovery: Analyst Sees Steady Margins With Ongoing Inventory Management

Published 29/04/2024, 16:12
© Reuters.  Microchip Technology's Path To Recovery: Analyst Sees Steady Margins With Ongoing Inventory Management
MCHP
-

Benzinga - by Anusuya Lahiri, Benzinga Editor.

Piper Sandler analyst Harsh V. Kumar reiterated a Neutral rating on Microchip Technology Inc (NASDAQ:MCHP) with a price target of $80 on April 26.

The re-rating reflected the timing of a potential macro recovery.

Kumar noted that the company is continuing the inventory-clearing process and positioning itself for a recovery in the second half of the year for most of its business.

Also Read: Marvell Analyst Tags Stock as Top Pick for AI Boom, Predicts Significant Industry Upswing

Specifically, inventory clearances are progressing in the auto and industrial industries, and management is seeing green shoots in these markets.

The analyst noted that management intends to significantly undership demand at this time in order to reduce inventory across its channels. According to comments made within the quarter, MCHP still anticipates revenue to remain roughly flat as they enter the guidance for the second calendar quarter.

The inventory recovery, coupled with the operating expenditure actions, positions MCHP's model to benefit when demand trends swing up post-inventory clearances, according to Kumar. On the gross margin side, the company is adjusting its utilization accordingly due to the magnitude and sharpness of the downturn.

Kumar said that in the longer term, the company remains steadfast in aspiring to reach 68% gross margin levels along with 45% operating margins. The current margin levels are artificially low due to the current cycle, and the company is set to achieve increased leverage, as per the analyst. He said that margin recovery should be driven by mix and utilization improvements as revenue growth resumes.

The analyst highlighted that despite the downtrend in the business and demand outlook, Microchip is continuing to keep capex for the overall business at historical levels. Additionally, per media reports, the company has also won ~$162 million in a grant through the CHIPS Act. Kumar noted that this capex spend will position MCHP well for the next business cycle after the inventory recovery.

Kumar projected fourth-quarter revenue and EPS of $1.33 billion and $0.57.

Microchip Technology stock gained over 24% in the last 12 months. Investors can gain exposure to the stock via Columbia ETF Trust I Columbia Seligman Semiconductor And Technology ETF (NYSE:SEMI) and First Trust Nasdaq Semiconductor ETF (NASDAQ:FTXL).

Price Action: MCHP shares are down 0.16% at $93.45 premarket at the last check Monday.

Now Read: Broadcom, Marvell Set To Capitalize On AI Investments From Microsoft, Alphabet, Meta: JPMorgan

Image generated using artificial intelligence via Midjourney.

Latest Ratings for MCHP

DateFirmActionFromTo
Mar 2022UBSMaintainsBuy
Feb 2022RosenblattMaintainsBuy
Jan 2022UBSUpgradesNeutralBuy
View More Analyst Ratings for MCHP

View the Latest Analyst Ratings

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.